Hantavirus Pandemic 2026

Hantavirus risk has faded to the point where the market no longer treats it as a distinct story. Polymarket's headline Hantavirus pandemic in 2026? trades at 3.65¢ on roughly $31k of 24-hour volume—still by far the deepest book in the stack—while Kalshi's WHO Public Health Emergency of International Concern mirror sits at 6¢ on about $285.

The notable development is the inversion below. Polymarket now prices a generic new pandemic in 2026 at 6.5¢, nearly double its hantavirus line. In other words the book has stopped pricing a hantavirus-specific premium entirely and now rates the named pathogen as less likely than an unnamed one. That is the market saying the MV Hondius cluster is contained. This workspace keeps the headline Singles side by side, the origin question that is still open, and the broader 2026 pandemic-risk books that give the hantavirus number its context.

Polymarket's Hantavirus pandemic in 2026? at 3.65¢ paired with Kalshi's WHO PHEIC for hantavirus Single at 6¢. Same story, two settlement primitives—pandemic-definition against PHEIC declaration—which is most of why the Kalshi line sits higher. A PHEIC is a much lower bar than a pandemic, and it is declared by a committee rather than triggered by case counts.

The June 30 Polymarket outbreak and lab-leak checkpoints both settled No and have been retired. What remains of the forensic question lives on Manifold: whether the MV Hondius outbreak is traced to rats aboard the ship itself, currently near 9.2% and the only line in the workspace that has not fallen. Polymarket has not listed a replacement dated checkpoint, so this row runs half width by design rather than carrying a settled book.

Year-level pandemic questions without the hantavirus narrowing. Polymarket's New pandemic in 2026? prices at 6.5¢ and Kalshi's at 5.5¢—and the Polymarket line now sits nearly three cents above its own hantavirus book. The spread between these and the hantavirus-specific Singles is the cleanest measure of how much of the pricing is pathogen-attributable, and right now the answer is none of it.

Manifold's mirror of the Polymarket pandemic Single reads 1¢ against Polymarket's 3.65¢—a wider relative gap than it looks, since the play-money book is pricing the same question at roughly a quarter the probability. The hantavirus-vaccine Single at 5.5¢ is the asymmetric-upside tail; it reprices on regulatory news rather than case counts and has been flat for weeks.

• Hantavirus now trades below generic pandemic risk. Polymarket has the named pathogen at 3.65¢ and an unnamed new pandemic at 6.5¢. That inversion is the single most informative thing in the stack—it means the specific outbreak premium has fully decayed. A move back above the generic line would be the first sign of renewed concern.
• The cross-exchange gap on the headline is definitional, not informational. Kalshi's 6¢ WHO-declaration line against Polymarket's 3.65¢ pandemic line reflects a lower settlement bar, not disagreement. Watch for the gap to narrow, which would imply one book is repricing.
• Manifold reads a quarter of Polymarket. The play-money mirror at 1¢ is the most bearish book in the workspace. Persistent gaps of this size on thin books usually reflect stale quotes rather than a view.
• The MV Hondius origin question is the only line still holding. Still open on Manifold near 9.2%. A confirmed shipboard origin would cap the outbreak narrative; anything pointing at a wider reservoir would not.
• Volume as the real signal. Every book here except the Polymarket headline is thin—Kalshi's PHEIC line turns over under $300 a day. A price move on a few hundred dollars of flow is noise. Only the $31k Polymarket book should be read as a price.